Tuesday, 31 March 2020

BioTech News

  • Japan to develop vaccine for H7N9 bird flu

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: A panel of experts at the Health, Labor and Welfare Ministry of Japan will start producing a vaccine for the H7N9 strain of avian influenza, according to a report published by Th...Read more

  • BioDiem partners with VIVALIS for vaccine development

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

    Singapore: Australian vaccine development company BioDiem announced that it has begun research collaboration with France-based VIVALIS, a biopharmaceutical company with expertise in vaccine...Read more

  • Cornavirus pioneers lauded by Nature magazine

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2013

    Singapore: The editor of Nature Medicine has acknowledged Lindsley F Kimball Research Institute, which is located at NYBC's Laboratory of Viral Immunology, in the August 2013 edition. The ...Read more

  • WaferGen, Qiagen sign Next-Gen sequencing deal

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2013

    Singapore: WaferGen Bio-systems announced a co-marketing agreement with Qiagen for the promotion of certain products in Japan in the areas of genomics platforms such as Next-Gen sequencing ...Read more

  • Inovio malaria DNA vaccine shows +ve results

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2013

    Singapore: Inovio Pharmaceuticals revealed that its SynCon DNA vaccine has demonstrated strong and durable antibody and T-cell immune responses in small animals and non-human primates. The ...Read more

  • Avexa to invest in mining to fund drug development

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2012

    Singapore: How far will a drug company go to fund drug discovery and development? Melborne-based biotechnology company Avexa, which is developing a treatment for drug-resistant HIV among ot...Read more

  • A*Star scientists discover new class of WBCs

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered a new class of white blood cells in human lung and gut tissues that play a critical role as the first l...Read more

  • Researchers find new link to study brain tumor

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2012

    Singapore: A joint study by researchers at the National Neuroscience Institute (NNI), National University of Singapore (NUS), and Singapore Institute for Clinical Sciences (SICS), A*STAR, h...Read more

  • Shimadzu India aims at 15-20% growth

    BioTech |  Influencers | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    With a view of expanding their customer base, Shimadzu Analytical India has been taking concrete steps towards connecting with their customers through various initiatives. Recently, it orga...Read more

  • European authority finds study on GM maize inadequate

    BioTech |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Oct, 2012

    Singapore: The European Food Safety Authority has concluded that a recent paper raising concerns about the potential toxicity of genetically modified (GM) maize NK603 and of a herbicide con...Read more

  • ICRISAT celebrates 40th birthday

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 27 Sep, 2012

    Bangalore: The International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) held a program in its Patancheru campus to commemorate its 40th anniversary. The chief guest of the...Read more

  • New Zealand's Biomatters wins Microsoft award

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 15 May, 2012

    Singapore: Biomatters, which is known for developing the Geneious Pro, won the Microsoft Hi-Tech Emerging Company Award at the 2012 NZ Hi-Tech Awards. Dr Brett Ammundsen, director and CEO,...Read more

  • Lawrence Gozlan is part of AusBiotech board

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 28 Mar, 2013

    Singapore: AusBiotech has appointed Mr Lawrence Gozlan as a non-executive director to its board. He has experience in global capital markets and is a specialist in life sciences investing. ...Read more

  • Millennium starts ph III trial for multiple myeloma drug

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Millennium: The Takeda Oncology Company, has initiated an international phase III clinical trial evaluating MLN9708 in patients with relapsed or refractory multiple myeloma. The ...Read more

  • LanzaTech adds oil and gas veteran to its board

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

    Singapore: LanzaTech, a producer of low-carbon fuels and chemicals from carbon-containing gases, appointed of Datuk Ir (Dr) Abdul Rahim Hj Hashim, the current president of the Malaysian Ga...Read more

  • Dr Chi-huey Wong: Pushing biotech growth in Taiwan

    BioTech |  Influencers | By Piyusha Chatterjee | 0 Comment | 09 Jul, 2012

    Scientist, entrepreneur, administrator, adviser. Dr Chi-Huey Wong, the ninth president of Academia Sinica, has donned many hats in his career spanning over 30 years. Now, in his second term...Read more

  • Biosimilars guidelines: A step in the right direction for India

    BioTech |  Analysis | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2012

    The announcement of the new biosimilars guidelines, "Guidelines on Similar Biologics: Regulatory Requirements for Marketing Authorization in India", by the Indian government is a welcome mo...Read more

  • Life science leaders to converge at Biologics World China in Nov

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2012

    Singapore: China is undergoing major healthcare reform and the bio and pharmaceutical market is expected to maintain double digit growth of approximately 20 percent to reach over $35 billio...Read more